These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2653399)

  • 21. Intracellular glutathione and cytotoxicity of platinum complexes.
    Pendyala L; Creaven PJ; Perez R; Zdanowicz JR; Raghavan D
    Cancer Chemother Pharmacol; 1995; 36(4):271-8. PubMed ID: 7628045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.
    Rose WC; Basler GA
    In Vivo; 1990; 4(6):391-6. PubMed ID: 2103379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New platinum agents. A comparison in ovarian cancer.
    Kelland LR; McKeage MJ
    Drugs Aging; 1994 Aug; 5(2):85-95. PubMed ID: 7981487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of murine tumour models and their acquired platinum-resistant counterparts in the evaluation of novel platinum antitumour agents: a cautionary note.
    Goddard PM; Valenti MR; Harrap KR
    Ann Oncol; 1991 Sep; 2(8):535-40. PubMed ID: 1793720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
    Hecquet B; Caty A; Fournier C; Lefebvre JL; Adenis L
    Bull Cancer; 1987; 74(4):433-6. PubMed ID: 3311237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
    Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
    Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
    Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.
    Manzotti C; Pratesi G; Menta E; Di Domenico R; Cavalletti E; Fiebig HH; Kelland LR; Farrell N; Polizzi D; Supino R; Pezzoni G; Zunino F
    Clin Cancer Res; 2000 Jul; 6(7):2626-34. PubMed ID: 10914703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
    Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.
    Schroyens W; Dodion P; Rozencweig M
    J Cancer Res Clin Oncol; 1990; 116(4):392-6. PubMed ID: 2202731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Nicolson MC; Orr RM; O'Neill CF; Harrap KR
    Neoplasma; 1992; 39(3):189-95. PubMed ID: 1528325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR
    Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
    Sasaki Y; Shinkai T; Eguchi K; Tamura T; Ohe Y; Ohmori T; Saijo N
    Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study.
    Weiss G; Green S; Alberts DS; Thigpen JT; Hines HE; Hanson K; Pierce HI; Baker LH; Goodwin JW
    Eur J Cancer; 1991; 27(2):135-8. PubMed ID: 1827275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro testing of platinum-based drugs on a panel of human ovarian tumour cell lines.
    Garner CM; Hubbold LM; Chakraborti PR
    Br J Biomed Sci; 2002; 59(1):15-9. PubMed ID: 12000179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase.
    Deng HB; Adikari M; Parekh HK; Simpkins H
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):301-7. PubMed ID: 15138708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platinum coordination complexes which circumvent cisplatin resistance.
    Harrap KR; Kelland LR; Jones M; Goddard PM; Orr RM; Morgan SE; Murrer BA; Abrams MJ; Giandomenico CM; Cobbleigh T
    Adv Enzyme Regul; 1991; 31():31-43. PubMed ID: 1877393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential properties of cisplatin and tetraplatin with respect to cytotoxicity and perturbation of cellular glutathione levels.
    Müller MR; Wright KA; Twentyman PR
    Cancer Chemother Pharmacol; 1991; 28(4):273-6. PubMed ID: 1879044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.